| Product Code: ETC6750015 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Parkinsons Disease Treatment Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Parkinsons Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 China Parkinsons Disease Treatment Market - Industry Life Cycle |
3.4 China Parkinsons Disease Treatment Market - Porter's Five Forces |
3.5 China Parkinsons Disease Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 China Parkinsons Disease Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Parkinsons Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in China |
4.2.2 Growing awareness and diagnosis rates of Parkinson's disease |
4.2.3 Advancements in medical technology and treatment options for Parkinson's disease |
4.2.4 Supportive government initiatives and policies for healthcare infrastructure development |
4.2.5 Rising healthcare expenditure and improving access to healthcare services |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease treatment and medications |
4.3.2 Limited availability of specialized healthcare professionals for Parkinson's disease management |
4.3.3 Stringent regulatory requirements for new treatment approvals |
4.3.4 Cultural stigma and lack of awareness leading to delayed diagnosis and treatment initiation |
4.3.5 Potential side effects and complications associated with existing Parkinson's disease treatments |
5 China Parkinsons Disease Treatment Market Trends |
6 China Parkinsons Disease Treatment Market, By Types |
6.1 China Parkinsons Disease Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 China Parkinsons Disease Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 China Parkinsons Disease Treatment Market Revenues & Volume, By Carbidopa-Levodopa, 2021- 2031F |
6.1.4 China Parkinsons Disease Treatment Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F |
6.1.5 China Parkinsons Disease Treatment Market Revenues & Volume, By MAO-B Inhibitors, 2021- 2031F |
6.1.6 China Parkinsons Disease Treatment Market Revenues & Volume, By COMT Inhibitors, 2021- 2031F |
6.1.7 China Parkinsons Disease Treatment Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 China Parkinsons Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Parkinsons Disease Treatment Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 China Parkinsons Disease Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 China Parkinsons Disease Treatment Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.2.4 China Parkinsons Disease Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 China Parkinsons Disease Treatment Market Import-Export Trade Statistics |
7.1 China Parkinsons Disease Treatment Market Export to Major Countries |
7.2 China Parkinsons Disease Treatment Market Imports from Major Countries |
8 China Parkinsons Disease Treatment Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for Parkinson's disease patients in China |
8.2 Number of clinical trials and research studies focused on Parkinson's disease treatments in China |
8.3 Adoption rate of advanced treatment modalities such as deep brain stimulation (DBS) for Parkinson's disease management |
8.4 Percentage of Parkinson's disease patients receiving multidisciplinary care and support services |
8.5 Patient-reported outcomes related to quality of life and symptom management for Parkinson's disease patients in China |
9 China Parkinsons Disease Treatment Market - Opportunity Assessment |
9.1 China Parkinsons Disease Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 China Parkinsons Disease Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Parkinsons Disease Treatment Market - Competitive Landscape |
10.1 China Parkinsons Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 China Parkinsons Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here